• DOI:10.1182/ASHEDUCATION-2003.1.102
Corpus ID: 10176275

Pediatric acute lymphoblastic leukemia.

@article{Carroll2003PediatricAL,
  title={Pediatric acute lymphoblastic leukemia.},
  author={W. Carroll and D. Bhojwani and D. Min and E. Raetz and M. Relling and S. Davies and J. Downing and C. Willman and John Calvin Reed},
  journal={Hematology. American Society of Hematology. Education Program},
  year={2003},
  pages={
          102-31
        }
}

• W. Carroll, D. Bhojwani, +6 authors John Calvin Reed
• Published 2003
• Medicine
• Hematology. American Society of Hematology. Education Program

The outcome for children with acute lymphoblastic leukemia (ALL) has improved dramatically with current therapy resulting in an event free survival exceeding 75% for most patients. However significant challenges remain including developing better methods to predict which patients can be cured with less toxic treatment and which ones will benefit from augmented therapy. In addition, 25% of patients fail therapy and novel treatments that are focused on undermining specifically the leukemic… Expand

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed